1. Identification of the clinical and neuroimaging characteristics in children with neuromyelitis optica spectrum disorders: a case series
- Author
-
Zhan Zhang, Xing-lou Liu, Sai-nan Shu, Ling-ling Liu, Hua Zhou, and Feng Fang
- Subjects
Pediatrics ,medicine.medical_specialty ,Expanded Disability Status Scale ,medicine.diagnostic_test ,business.industry ,Encephalopathy ,Magnetic resonance imaging ,Disease ,medicine.disease ,Neuroimaging ,Pediatrics, Perinatology and Child Health ,Cohort ,medicine ,Biomarker (medicine) ,Original Article ,Optic neuritis ,business - Abstract
Background Childhood neuromyelitis optica spectrum disorders (NMOSDs) may cause visual impairment and brain or spinal cord damage, and the effects may be permanent if left untreated. Since the incidence of NMOSD cases in children is relatively low, the understanding of NMOSD among children is inadequate. Methods This investigation examined the clinical and neuroimaging characteristics of childhood NMOSD. We retrospectively analyzed the clinical information of 11 NMOSD patients admitted to our centre from 2012 to 2021. The disease status was assessed by the Expanded Disability Status Scale (EDSS) score. Results The two major symptoms observed in the study cohort were optic neuritis (ON) (9/11) and encephalopathy (7/11). Antibody tests were performed on 8 children, 2 of whom showed serum aquaporin 4 (AQP4) antibody positivity, and another 2 presented with serum myelin oligodendrocyte glycoprotein (MOG) antibody positivity. All patients showed white matter hyperintensity on magnetic resonance imaging (MRI) scans. Interestingly, a rare radiological sign, enlarged perivascular space (PVS), which is more commonly observed in the elderly or adults, was found in 4 participants with more severe clinical manifestations. Conclusions While NMOSD in children is less commonly diagnosed through clinical evaluations, the symptoms of ON and encephalopathy should raise the possibility of the disease. As the diagnosis of NMOSD in children is relatively difficult, enlarged PVS may represent a promising biomarker for the diagnosis and evaluation of NMOSD.
- Published
- 2021
- Full Text
- View/download PDF